United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $834,836,763.10
- April 17, 2025
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 5, 2015 | Director | 3,000 | $149.63 | Sell | $448,890.00 | |
Nov. 5, 2015 | CEO | 4,115 | $149.16 | Sell | $613,793.40 | |
Nov. 3, 2015 | Director | 7,500 | $153.22 | Sell | $1,149,150.00 | |
Oct. 29, 2015 | CEO | 9,662 | $141.89 | Sell | $1,370,941.18 | |
Oct. 28, 2015 | CEO | 2,211 | $136.58 | Sell | $301,978.38 | |
Oct. 26, 2015 | CEO | 2,592 | $127.13 | Sell | $329,520.96 | |
Oct. 22, 2015 | CEO | 9,662 | $122.40 | Sell | $1,182,628.80 | |
Oct. 21, 2015 | CEO | 2,211 | $123.63 | Sell | $273,345.93 | |
Oct. 19, 2015 | CEO | 2,592 | $126.71 | Sell | $328,432.32 | |
Oct. 15, 2015 | CEO | 9,662 | $126.22 | Sell | $1,219,537.64 | |
Oct. 14, 2015 | CEO | 2,211 | $123.53 | Sell | $273,124.83 | |
Oct. 12, 2015 | CEO | 2,592 | $123.51 | Sell | $320,137.92 | |
Oct. 8, 2015 | CEO | 9,662 | $122.48 | Sell | $1,183,401.76 | |
Oct. 7, 2015 | CEO | 2,211 | $120.88 | Sell | $267,265.68 | |
Oct. 5, 2015 | CEO | 2,592 | $126.88 | Sell | $328,872.96 | |
Oct. 1, 2015 | EVP | 6,000 | $129.38 | Sell | $776,280.00 | |
Oct. 1, 2015 | Director | 3,000 | $131.32 | Sell | $393,960.00 | |
Oct. 1, 2015 | CEO | 6,326 | $131.11 | Sell | $829,401.86 | |
Sept. 29, 2015 | Director | 5,000 | $139.19 | Sell | $695,950.00 | |
Sept. 29, 2015 | CEO | 2,592 | $134.25 | Sell | $347,976.00 | |
Sept. 24, 2015 | CEO | 9,662 | $139.26 | Sell | $1,345,530.12 | |
Sept. 23, 2015 | CEO | 2,211 | $142.05 | Sell | $314,072.55 | |
Sept. 21, 2015 | CEO | 2,592 | $150.81 | Sell | $390,899.52 | |
Sept. 17, 2015 | CEO | 9,662 | $152.02 | Sell | $1,468,817.24 | |
Sept. 16, 2015 | CEO | 2,211 | $151.93 | Sell | $335,917.23 | |
Sept. 14, 2015 | CEO | 2,592 | $153.08 | Sell | $396,783.36 | |
Sept. 10, 2015 | CEO | 4,115 | $152.95 | Sell | $629,389.25 | |
Sept. 9, 2015 | CEO | 2,211 | $152.77 | Sell | $337,774.47 | |
Sept. 8, 2015 | CEO | 2,592 | $152.80 | Sell | $396,057.60 | |
Sept. 3, 2015 | Director | 3,000 | $155.54 | Sell | $466,620.00 | |
Sept. 3, 2015 | CEO | 9,662 | $153.67 | Sell | $1,484,759.54 | |
Sept. 2, 2015 | CEO | 2,211 | $151.12 | Sell | $334,126.32 | |
Aug. 31, 2015 | CEO | 2,592 | $153.50 | Sell | $397,872.00 | |
Aug. 27, 2015 | CEO | 9,662 | $160.37 | Sell | $1,549,494.94 | |
Aug. 26, 2015 | CEO | 2,211 | $155.47 | Sell | $343,744.17 | |
Aug. 24, 2015 | CEO | 2,592 | $155.36 | Sell | $402,693.12 | |
Aug. 20, 2015 | CEO | 9,662 | $166.58 | Sell | $1,609,495.96 | |
Aug. 19, 2015 | CEO | 2,211 | $167.13 | Sell | $369,524.43 | |
Aug. 17, 2015 | CEO | 2,592 | $166.61 | Sell | $431,853.12 | |
Aug. 13, 2015 | CEO | 9,662 | $165.05 | Sell | $1,594,713.10 | |
July 27, 2015 | CEO | 2,592 | $166.38 | Sell | $431,256.96 | |
July 23, 2015 | CEO | 4,115 | $176.38 | Sell | $725,803.70 | |
July 22, 2015 | CEO | 2,211 | $174.55 | Sell | $385,930.05 | |
July 20, 2015 | CEO | 2,592 | $177.92 | Sell | $461,168.64 | |
July 16, 2015 | CEO | 9,662 | $175.51 | Sell | $1,695,777.62 | |
July 15, 2015 | CEO | 2,211 | $176.77 | Sell | $390,838.47 | |
July 13, 2015 | CEO | 2,592 | $172.42 | Sell | $446,912.64 | |
July 9, 2015 | CEO | 9,662 | $168.04 | Sell | $1,623,602.48 | |
July 8, 2015 | CEO | 2,211 | $167.13 | Sell | $369,524.43 | |
July 6, 2015 | CEO | 2,592 | $170.66 | Sell | $442,350.72 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, Judy D. Olian, R Paul Gray, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, and DWEK RAYMOND
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on April 17, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.